Search results
Results from the WOW.Com Content Network
Toggle Reuptake inhibitors subsection. 2.1 Dopamine transporter (DAT) inhibitors. 2.2 Vesicular monoamine transporter ... Dopamine. This is a list of dopaminergic drugs.
A dopamine reuptake inhibitor (DRI) is a class of drug which acts as a reuptake inhibitor of the monoamine neurotransmitter dopamine by blocking the action of the dopamine transporter (DAT). Reuptake inhibition is achieved when extracellular dopamine not absorbed by the postsynaptic neuron is blocked from re-entering the presynaptic neuron.
Serotonin–norepinephrine–dopamine reuptake inhibitors (57 P) Pages in category "Dopamine reuptake inhibitors" The following 99 pages are in this category, out of 99 total.
At present, only one norepinephrine-dopamine reuptake inhibitor is approved by the FDA to treat depression: bupropion (Wellbutrin). It boosts the concentration of norepinephrine and dopamine ...
Chemical/generic names are listed first, with brand names in parentheses. All drugs listed are approved specifically for major depressive disorder unless noted otherwise. Selective serotonin reuptake inhibitors (SSRIs)
The skeletal structure of norepinephrine The skeletal structure of dopamine. A norepinephrine–dopamine reuptake inhibitor (NDRI) is a drug used for the treatment of clinical depression, attention deficit hyperactivity disorder (ADHD), narcolepsy, and the management of Parkinson's disease.
Amitifadine (DOV-21947; EB-1010) – serotonin, norepinephrine, and dopamine reuptake inhibitor [172] AN-788 (NSD-788) – serotonin and dopamine reuptake inhibitor [173] ANAVEX 1-41 (blarcamesine analogue) – sigma σ 1 receptor agonist, muscarinic acetylcholine receptor modulator, and sodium and chloride channel modulator [174]
Medifoxamine (Cledial, Gerdaxyl) is an antidepressant that appears to act as an SDRI as well as a 5-HT 2 receptor antagonist. [3] Sibutramine (Reductil, Meridia, Siredia, Sibutrex) is a withdrawn anorectic that itself as a molecule in vitro is an SNDRI but preferentially an SDRI, with 18.3- and 5.8-fold preference for inhibiting the reuptake of serotonin and dopamine over norepinephrine ...